In the last 12 months, insiders at Passage BIO, Inc. ($PASG) filed 113 transactions with the SEC: 12 open-market purchases totaling $2,484,883 and 36 sales totaling $1,185,737. Net insider sentiment: net buying.
Passage BIO, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- ORBIMED ADVISORS LLC (TenPercentOwner) — 27 transactions totaling $2,015,116
- Lynx1 Capital Management LP (TenPercentOwner) — 10 transactions totaling $1,483,118
- Chou William (PRESIDENT AND CEO) — 7 transactions totaling $75,159
- Borthwick Kathleen (CFO) — 10 transactions totaling $39,708
- Cale Edgar B. (GC & Corporate Secretary) — 4 transactions totaling $14,390
View all SEC Filings for Passage BIO, Inc. (PASG).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Borthwick Kathleen | CFO | A | Employee Stock Option (right to buy) | 15610 | $0.00 | 15,610.0000 | 3,172,870 | 9999.99% | 0.49% |
| March 16, 2026 | Chou William | PRESIDENT AND CEO | A | Employee Stock Option (right to buy) | 58000 | $0.00 | 58,000.0000 | 3,172,870 | 9999.99% | 1.83% |
| Jan. 8, 2026 | Chou William | PRESIDENT AND CEO | M | Restricted Stock Unit | 10000 | $0.00 | 10,000.0000 | 3,172,870 | 50.00% | 0.32% |
| Jan. 8, 2026 | Chou William | PRESIDENT AND CEO | M | Common Stock | 10000 | $0.00 | 10,600.0000 | 3,172,870 | 1666.67% | 0.32% |
| Jan. 8, 2026 | Chou William | PRESIDENT AND CEO | S | Common Stock | 4076 | $18.44 | 6,524.0000 | 3,172,870 | 38.45% | 0.13% |
| Jan. 8, 2026 | Borthwick Kathleen | CFO | M | Common Stock | 5000 | $0.00 | 7,464.0000 | 3,172,870 | 202.92% | 0.16% |
| Jan. 8, 2026 | Borthwick Kathleen | CFO | S | Common Stock | 2062 | $18.44 | 5,402.0000 | 3,172,870 | 27.63% | 0.06% |
| Jan. 8, 2026 | Borthwick Kathleen | CFO | M | Restricted Stock Unit | 5000 | $0.00 | 5,000.0000 | 3,172,870 | 50.00% | 0.16% |
| Jan. 15, 2025 | Chou William | PRESIDENT AND CEO | A | Restricted Stock Unit | 20000 | $0.00 | 20,000.0000 | 3,078,665 | 9999.99% | 0.65% |
| Jan. 15, 2025 | Borthwick Kathleen | CFO | A | Restricted Stock Unit | 10000 | $0.00 | 10,000.0000 | 3,078,665 | 9999.99% | 0.32% |
| Sept. 15, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common Stock | 11900 | $6.99 | 623,704.0000 | 3,168,933 | 1.95% | 0.38% |
| Sept. 12, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common Stock | 19783 | $6.99 | 611,804.0000 | 3,168,933 | 3.34% | 0.62% |
| Sept. 11, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common stock, $0.0001 par value per share (Common Stock) | 325 | $6.96 | 592,021.0000 | 3,168,933 | 0.05% | 0.01% |
| July 24, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common Stock | 66423 | $5.71 | 591,696.0000 | 3,168,933 | 12.65% | 2.10% |
| July 23, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common Stock | 49302 | $5.74 | 525,273.0000 | 3,168,933 | 10.36% | 1.56% |
| July 22, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common stock, $0.0001 par value per share ("Common Stock") | 13123 | $5.44 | 475,971.0000 | 3,168,933 | 2.84% | 0.41% |
| June 26, 2025 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 213257 | $0.33 | 6,066,343.0000 | 62,109,991 | 3.40% | 0.34% |
| June 24, 2025 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 231600 | $0.35 | 6,418,400.0000 | 62,109,991 | 3.48% | 0.37% |
| June 25, 2025 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 138800 | $0.33 | 6,279,600.0000 | 62,109,991 | 2.16% | 0.22% |
| May 28, 2025 | Kapadia Sandip | Not found | A | Director Stock Option (right to buy) | 201857 | $0.00 | 201,857.0000 | 62,109,991 | 9999.99% | 0.33% |
| May 28, 2025 | GOWEN MAXINE | Not found | A | Director Stock Option (right to buy) | 201857 | $0.00 | 201,857.0000 | 62,109,991 | 9999.99% | 0.33% |
| May 28, 2025 | Countouriotis Athena | Not found | A | Director Stock Option (right to buy) | 201857 | $0.00 | 201,857.0000 | 62,109,991 | 9999.99% | 0.33% |
| May 28, 2025 | Porter Derrell | Not found | A | Director Stock Option (right to buy) | 201857 | $0.00 | 201,857.0000 | 62,109,991 | 9999.99% | 0.33% |
| May 28, 2025 | Islam Saqib | Not found | A | Director Stock Option (right to buy) | 201857 | $0.00 | 201,857.0000 | 62,109,991 | 9999.99% | 0.33% |
| May 28, 2025 | Sondhi Dolan | Not found | A | Director Stock Option (right to buy) | 201857 | $0.00 | 201,857.0000 | 62,109,991 | 9999.99% | 0.33% |
| May 28, 2025 | Kassberg Thomas Richard | Not found | A | Director Stock Option (right to buy) | 143789 | $0.00 | 143,789.0000 | 62,109,991 | 9999.99% | 0.23% |
| April 22, 2025 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 78049 | $0.34 | 6,807,523.0000 | 62,109,991 | 1.13% | 0.13% |
| April 23, 2025 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 89328 | $0.34 | 6,718,195.0000 | 62,109,991 | 1.31% | 0.14% |
| April 24, 2025 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 68195 | $0.32 | 6,650,000.0000 | 62,109,991 | 1.02% | 0.11% |
| April 17, 2025 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 77090 | $0.33 | 6,885,572.0000 | 62,109,991 | 1.11% | 0.12% |
| April 15, 2025 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 10326 | $0.38 | 7,024,300.0000 | 62,109,991 | 0.15% | 0.02% |
| April 16, 2025 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 61638 | $0.33 | 6,962,662.0000 | 62,109,991 | 0.88% | 0.10% |
| March 15, 2025 | Chou William | PRESIDENT AND CEO | A | Employee Stock Option (right to buy) | 779533 | $0.00 | 779,533.0000 | 3,078,665 | 9999.99% | 25.32% |
| March 15, 2025 | Borthwick Kathleen | CFO | A | Employee Stock Option (right to buy) | 278386 | $0.00 | 278,386.0000 | 3,078,665 | 9999.99% | 9.04% |
| March 15, 2025 | Cale Edgar B. | GC & CORPORATE SECRETARY | A | Employee Stock Option (right to buy) | 278386 | $0.00 | 278,386.0000 | 3,078,665 | 9999.99% | 9.04% |
| Feb. 10, 2025 | Borthwick Kathleen | CFO | M | Restricted Stock Unit | 8000 | $0.00 | 0.0000 | 3,078,665 | 100.00% | 0.26% |
| Feb. 11, 2025 | Borthwick Kathleen | CFO | S | Common Stock | 3183 | $0.53 | 41,283.0000 | 3,078,665 | 7.16% | 0.10% |
| Feb. 10, 2025 | Borthwick Kathleen | CFO | M | Common Stock | 8000 | $0.00 | 44,466.0000 | 3,078,665 | 21.94% | 0.26% |
| Jan. 14, 2025 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 79024 | $0.60 | 7,034,626.0000 | 3,078,665 | 1.11% | 2.57% |
| Jan. 13, 2025 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 17986 | $0.64 | 7,113,650.0000 | 3,078,665 | 0.25% | 0.58% |
| Jan. 10, 2025 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 126209 | $0.66 | 7,131,636.0000 | 3,078,665 | 1.74% | 4.10% |
| Jan. 6, 2025 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 19481 | $0.77 | 7,385,388.0000 | 3,078,665 | 0.26% | 0.63% |
| Jan. 7, 2025 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 52536 | $0.71 | 7,332,852.0000 | 3,078,665 | 0.71% | 1.71% |
| Jan. 8, 2025 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 75007 | $0.68 | 7,257,845.0000 | 3,078,665 | 1.02% | 2.44% |
| Dec. 27, 2024 | Lynx1 Capital Management LP | TenPercentOwner | P | Common stock, $0.0001 par value per share | 373645 | $0.65 | 9,256,953.0000 | 3,146,582 | 4.21% | 11.88% |
| Dec. 20, 2024 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 230321 | $0.60 | 7,404,869.0000 | 3,146,582 | 3.02% | 7.32% |
| Dec. 9, 2024 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 54181 | $0.84 | 7,643,285.0000 | 3,146,582 | 0.70% | 1.72% |
| Dec. 10, 2024 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 8015 | $0.80 | 7,635,270.0000 | 3,146,582 | 0.10% | 0.25% |
| Dec. 11, 2024 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 80 | $0.80 | 7,635,190.0000 | 3,146,582 | 0.00% | 0.00% |
| Dec. 4, 2024 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 76200 | $0.79 | 7,718,369.0000 | 3,146,582 | 0.98% | 2.42% |
| Dec. 6, 2024 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 20903 | $0.82 | 7,697,466.0000 | 3,146,582 | 0.27% | 0.66% |
| Nov. 25, 2024 | Lynx1 Capital Management LP | TenPercentOwner | P | Common stock, $0.0001 par value per share ("Common Stock") | 259998 | $0.56 | 8,686,953.0000 | 3,146,582 | 3.09% | 8.26% |
| Nov. 26, 2024 | Lynx1 Capital Management LP | TenPercentOwner | P | Common Stock | 167055 | $0.71 | 8,854,008.0000 | 3,146,582 | 1.92% | 5.31% |
| Nov. 27, 2024 | Lynx1 Capital Management LP | TenPercentOwner | P | Common Stock | 29300 | $0.67 | 8,883,308.0000 | 3,146,582 | 0.33% | 0.93% |
| Sept. 30, 2024 | Cale Edgar B. | GC & CORPORATE SECRETARY | A | Employee Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 3,142,537 | 9999.99% | 1.59% |
| Sept. 30, 2024 | Kassberg Thomas Richard | Not found | A | Employee Stock Option (right to buy) | 174139 | $0.00 | 174,139.0000 | 3,142,537 | 9999.99% | 5.54% |
| Sept. 19, 2024 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 39300 | $0.71 | 7,794,569.0000 | 3,142,537 | 0.50% | 1.25% |
| Sept. 17, 2024 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 111400 | $0.73 | 7,859,500.0000 | 3,142,537 | 1.40% | 3.54% |
| Sept. 18, 2024 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 25631 | $0.73 | 7,833,869.0000 | 3,142,537 | 0.33% | 0.82% |
| Sept. 16, 2024 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 63100 | $0.74 | 7,970,900.0000 | 3,142,537 | 0.79% | 2.01% |
| May 21, 2024 | Kapadia Sandip | Not found | A | Director Stock Option (right to buy) | 47693 | $0.00 | 47,693.0000 | 56,295,540 | 9999.99% | 0.08% |
| May 21, 2024 | Countouriotis Athena | Not found | A | Director Stock Option (right to buy) | 47693 | $0.00 | 47,693.0000 | 56,295,540 | 9999.99% | 0.08% |
| May 21, 2024 | GOWEN MAXINE | Not found | A | Director Stock Option (right to buy) | 47693 | $0.00 | 47,693.0000 | 56,295,540 | 9999.99% | 0.08% |
| May 21, 2024 | Porter Derrell | Not found | A | Director Stock Option (right to buy) | 47693 | $0.00 | 47,693.0000 | 56,295,540 | 9999.99% | 0.08% |
| May 21, 2024 | Sondhi Dolan | Not found | A | Director Stock Option (right to buy) | 39092 | $0.00 | 39,092.0000 | 56,295,540 | 9999.99% | 0.07% |
| May 21, 2024 | Islam Saqib | Not found | A | Director Stock Option (right to buy) | 47693 | $0.00 | 47,693.0000 | 56,295,540 | 9999.99% | 0.08% |
| March 15, 2024 | Forman Mark S | CHIEF MEDICAL OFFICER | A | Employee Stock Option (right to buy) | 203000 | $0.00 | 203,000.0000 | 54,743,490 | 9999.99% | 0.37% |
| March 15, 2024 | Borthwick Kathleen | CFO | A | Employee Stock Option (right to buy) | 227000 | $0.00 | 227,000.0000 | 54,743,490 | 9999.99% | 0.41% |
| March 15, 2024 | Chou William | PRESIDENT AND CEO | A | Employee Stock Option (right to buy) | 575000 | $0.00 | 575,000.0000 | 54,743,490 | 9999.99% | 1.05% |
| March 15, 2024 | Cale Edgar B. | GC & CORPORATE SECRETARY | A | Employee Stock Option (right to buy) | 203000 | $0.00 | 203,000.0000 | 54,743,490 | 9999.99% | 0.37% |
| Feb. 10, 2024 | Forman Mark S | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 5000 | $0.00 | 10,000.0000 | 54,743,490 | 33.33% | 0.01% |
| Feb. 10, 2024 | Borthwick Kathleen | SVP, INTERIM CFO | M | Common Stock | 4000 | $0.00 | 29,936.0000 | 54,743,490 | 15.42% | 0.01% |
| Feb. 13, 2024 | Borthwick Kathleen | SVP, INTERIM CFO | S | Common Stock | 1470 | $0.97 | 28,466.0000 | 54,743,490 | 4.91% | 0.00% |
| Feb. 10, 2024 | Borthwick Kathleen | SVP, INTERIM CFO | M | Restricted Stock Unit | 4000 | $0.00 | 8,000.0000 | 54,743,490 | 33.33% | 0.01% |
| Feb. 10, 2024 | Forman Mark S | CHIEF MEDICAL OFFICER | M | Common Stock | 5000 | $0.00 | 50,269.0000 | 54,743,490 | 11.05% | 0.01% |
| Feb. 13, 2024 | Forman Mark S | CHIEF MEDICAL OFFICER | S | Common Stock | 1638 | $0.97 | 48,631.0000 | 54,743,490 | 3.26% | 0.00% |
| Aug. 16, 2021 | Forman Mark S | CHIEF MEDICAL OFFICER | A | Employee Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 53,885,651 | 9999.99% | 0.24% |
| Feb. 10, 2022 | Forman Mark S | CHIEF MEDICAL OFFICER | A | Employee Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 53,343,959 | 9999.99% | 0.05% |
| Feb. 10, 2022 | Forman Mark S | CHIEF MEDICAL OFFICER | A | Restricted Stock Unit | 15000 | $0.00 | 15,000.0000 | 53,343,959 | 9999.99% | 0.03% |
| Dec. 31, 2023 | Forman Mark S | Chief Medical Officer | M | Restricted Stock Unit | 50000 | $0.00 | 0.0000 | 54,789,410 | 100.00% | 0.09% |
| Dec. 31, 2023 | Borthwick Kathleen | SVP, Interim CFO | M | Common Stock | 30000 | $0.00 | 36,608.0000 | 54,789,410 | 454.00% | 0.05% |
| Jan. 2, 2024 | Borthwick Kathleen | SVP, Interim CFO | S | Common Stock | 10672 | $0.91 | 25,936.0000 | 54,743,490 | 29.15% | 0.02% |
| Dec. 31, 2023 | Borthwick Kathleen | SVP, Interim CFO | M | Restricted Stock Unit | 30000 | $0.00 | 0.0000 | 54,789,410 | 100.00% | 0.05% |
| Dec. 31, 2023 | Cale Edgar B. | GC & Corporate Secretary | M | Common Stock | 50000 | $0.00 | 61,808.0000 | 54,789,410 | 423.44% | 0.09% |
| Jan. 2, 2024 | Cale Edgar B. | GC & Corporate Secretary | S | Common Stock | 15813 | $0.91 | 45,995.0000 | 54,743,490 | 25.58% | 0.03% |
| Dec. 31, 2023 | Cale Edgar B. | GC & Corporate Secretary | M | Restricted Stock Unit | 50000 | $0.00 | 0.0000 | 54,789,410 | 100.00% | 0.09% |
| Jan. 2, 2024 | Forman Mark S | Chief Medical Officer | S | Common Stock | 15813 | $0.91 | 45,269.0000 | 54,743,490 | 25.89% | 0.03% |
| Dec. 31, 2023 | Forman Mark S | Chief Medical Officer | M | Common Stock | 50000 | $0.00 | 61,082.0000 | 54,789,410 | 451.18% | 0.09% |
| July 28, 2023 | King Simona | Chief Financial Officer | S | Common Stock | 11453 | $0.88 | 23,994.0000 | 54,683,817 | 32.31% | 0.02% |
| July 28, 2023 | King Simona | Chief Financial Officer | M | Common Stock | 31250 | $0.00 | 35,447.0000 | 54,683,817 | 744.58% | 0.06% |
| July 28, 2023 | King Simona | Chief Financial Officer | M | Restricted Stock Units | 31250 | $0.00 | 0.0000 | 54,683,817 | 100.00% | 0.06% |
| July 27, 2023 | Sondhi Dolan | Director | A | Director Stock Option (right to buy) | 48000 | $0.00 | 48,000.0000 | 54,683,817 | 9999.99% | 0.09% |
| July 28, 2023 | Borthwick Kathleen | SVP, Interim CFO | A | Employee Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 54,683,817 | 9999.99% | 0.04% |
| June 27, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | P | Common Stock | 617382 | $0.84 | 7,458,805.0000 | 54,618,799 | 9.02% | 1.13% |
| June 28, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | P | Common Stock | 575195 | $0.84 | 8,034,000.0000 | 54,618,799 | 7.71% | 1.05% |
| June 16, 2023 | Fotopoulos Alexandros | Chief Technical Officer | S | Common Stock | 4052 | $0.93 | 28,693.0000 | 54,618,799 | 12.37% | 0.01% |
| June 15, 2023 | Fotopoulos Alexandros | Chief Technical Officer | M | Restricted Stock Units | 12500 | $0.00 | 25,000.0000 | 54,618,799 | 33.33% | 0.02% |
| June 15, 2023 | Fotopoulos Alexandros | Chief Technical Officer | M | Common Stock | 12500 | $0.00 | 32,745.0000 | 54,618,799 | 61.74% | 0.02% |
| May 25, 2023 | Woiwode Thomas | Director | A | Director Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 54,618,799 | 9999.99% | 0.04% |
| May 25, 2023 | Countouriotis Athena | Director | A | Director Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 54,618,799 | 9999.99% | 0.04% |
| May 25, 2023 | Porter Derrell | Director | A | Director Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 54,618,799 | 9999.99% | 0.04% |
| May 25, 2023 | Kapadia Sandip | Director | A | Director Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 54,618,799 | 9999.99% | 0.04% |
| May 25, 2023 | Kamarck Michael E. | Director | A | Director Stock Option (Right to Buy) | 21567 | $0.00 | 21,567.0000 | 54,618,799 | 9999.99% | 0.04% |
| May 25, 2023 | Islam Saqib | Director | A | Director Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 54,618,799 | 9999.99% | 0.04% |
| May 25, 2023 | GOWEN MAXINE | Director | A | Director Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 54,618,799 | 9999.99% | 0.04% |
| April 18, 2023 | King Simona | Chief Financial Officer | M | Common Stock | 6250 | $0.00 | 6,250.0000 | 54,618,799 | 9999.99% | 0.01% |
| April 18, 2023 | King Simona | Chief Financial Officer | M | Restricted Stock Units | 6250 | $0.00 | 18,750.0000 | 54,618,799 | 25.00% | 0.01% |
| April 18, 2023 | King Simona | Chief Financial Officer | S | Common Stock | 2053 | $1.05 | 2,053.0000 | 54,618,799 | 50.00% | 0.00% |
| March 15, 2023 | Cale Edgar B. | GC & Corporate Secretary | A | Employee Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 54,429,023 | 9999.99% | 0.32% |
| March 15, 2023 | Forman Mark S | Chief Medical Officer | A | Employee Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 54,429,023 | 9999.99% | 0.32% |
| March 15, 2023 | King Simona | Chief Financial Officer | A | Employee Stock Option (right to buy) | 140000 | $0.00 | 140,000.0000 | 54,429,023 | 9999.99% | 0.26% |
| March 15, 2023 | Chou William | President and CEO | A | Employee Stock Option (right to buy) | 608615 | $0.00 | 608,615.0000 | 54,429,023 | 9999.99% | 1.12% |
| March 15, 2023 | Fotopoulos Alexandros | Chief Technical Officer | A | Employee Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 54,429,023 | 9999.99% | 0.32% |